187 related articles for article (PubMed ID: 11788478)
1. Inhibition of platelet-collagen interaction: an in vivo action of insulin abolished by insulin resistance in obesity.
Westerbacka J; Yki-Järvinen H; Turpeinen A; Rissanen A; Vehkavaara S; Syrjälä M; Lassila R
Arterioscler Thromb Vasc Biol; 2002 Jan; 22(1):167-72. PubMed ID: 11788478
[TBL] [Abstract][Full Text] [Related]
2. Platelet resistance to nitrates in obesity and obese NIDDM, and normal platelet sensitivity to both insulin and nitrates in lean NIDDM.
Anfossi G; Mularoni EM; Burzacca S; Ponziani MC; Massucco P; Mattiello L; Cavalot F; Trovati M
Diabetes Care; 1998 Jan; 21(1):121-6. PubMed ID: 9538982
[TBL] [Abstract][Full Text] [Related]
3. Obesity is associated with impaired platelet-inhibitory effect of acetylsalicylic acid in nondiabetic subjects.
Tamminen M; Lassila R; Westerbacka J; Vehkavaara S; Yki-Järvinen H
Int J Obes Relat Metab Disord; 2003 Aug; 27(8):907-11. PubMed ID: 12861231
[TBL] [Abstract][Full Text] [Related]
4. Platelet resistance to the antiaggregating effect of N-acetyl-L-cysteine in obese, insulin-resistant subjects.
Anfossi G; Russo I; Massucco P; Mattiello L; Trovati M
Thromb Res; 2003 Apr; 110(1):39-46. PubMed ID: 12877907
[TBL] [Abstract][Full Text] [Related]
5. Leptin does not play a major role in platelet aggregation in obesity and leptin deficiency.
Ozata M; Avcu F; Durmus O; Yilmaz I; Ozdemir IC; Yalcin A
Obes Res; 2001 Oct; 9(10):627-30. PubMed ID: 11595779
[TBL] [Abstract][Full Text] [Related]
6. Impaired synthesis and action of antiaggregating cyclic nucleotides in platelets from obese subjects: possible role in platelet hyperactivation in obesity.
Anfossi G; Russo I; Massucco P; Mattiello L; Doronzo G; De Salve A; Trovati M
Eur J Clin Invest; 2004 Jul; 34(7):482-9. PubMed ID: 15255785
[TBL] [Abstract][Full Text] [Related]
7. Is primary haemostasis controlled by a 'platelet delay time'? Formulation of a new hypothesis.
Kratzer MA
Platelets; 2003; 14(7-8):437-43. PubMed ID: 14713513
[TBL] [Abstract][Full Text] [Related]
8. Reversible shear-mediated platelet dysfunction during cardiac surgery as assessed by the PFA-100 platelet function analyzer.
Slaughter TF; Sreeram G; Sharma AD; El-Moalem H; East CJ; Greenberg CS
Blood Coagul Fibrinolysis; 2001 Mar; 12(2):85-93. PubMed ID: 11302482
[TBL] [Abstract][Full Text] [Related]
9. Marked resistance of the ability of insulin to decrease arterial stiffness characterizes human obesity.
Westerbacka J; Vehkavaara S; Bergholm R; Wilkinson I; Cockcroft J; Yki-Järvinen H
Diabetes; 1999 Apr; 48(4):821-7. PubMed ID: 10102699
[TBL] [Abstract][Full Text] [Related]
10. Desensitization of the platelet aggregation response to adrenaline during insulin-induced hypoglycaemia in man.
Trovati M; Anfossi G; Mularoni E; Massucco P; Cavalot F; Mattiello L; Emanuelli G
Diabet Med; 1990 Jun; 7(5):414-9. PubMed ID: 2142038
[TBL] [Abstract][Full Text] [Related]
11. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
Badimon JJ; Weng D; Chesebro JH; Fuster V; Badimon L
Thromb Haemost; 1994 Apr; 71(4):511-6. PubMed ID: 8052972
[TBL] [Abstract][Full Text] [Related]
12. Insulin increases guanosine-3',5'-cyclic monophosphate in human platelets. A mechanism involved in the insulin anti-aggregating effect.
Trovati M; Massucco P; Mattiello L; Mularoni E; Cavalot F; Anfossi G
Diabetes; 1994 Aug; 43(8):1015-9. PubMed ID: 7518780
[TBL] [Abstract][Full Text] [Related]
13. Relationship of hepatic and peripheral insulin resistance with plasminogen activator inhibitor-1 in Pima Indians.
Nagi DK; Tracy R; Pratley R
Metabolism; 1996 Oct; 45(10):1243-7. PubMed ID: 8843179
[TBL] [Abstract][Full Text] [Related]
14. Antithrombotic effects of peroxynitrite: inhibition and reversal of aggregation in human platelets.
Yin K; Lai PS; Rodriguez A; Spur BW; Wong PY
Prostaglandins; 1995 Sep; 50(3):169-78. PubMed ID: 8750213
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the aggregation responses of camel platelets.
Al Ghumlas AK; Gader AG
Vet Clin Pathol; 2013 Sep; 42(3):307-13. PubMed ID: 23919654
[TBL] [Abstract][Full Text] [Related]
16. Whole blood platelet aggregation in humans and animals: a comparative study.
Soloviev MV; Okazaki Y; Harasaki H
J Surg Res; 1999 Apr; 82(2):180-7. PubMed ID: 10090827
[TBL] [Abstract][Full Text] [Related]
17. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
Krishnamurthi S; Westwick J; Kakkar VV
Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
[TBL] [Abstract][Full Text] [Related]
18. Impaired insulin-induced platelet antiaggregating effect in obesity and in obese NIDDM patients.
Trovati M; Mularoni EM; Burzacca S; Ponziani MC; Massucco P; Mattiello L; Piretto V; Cavalot F; Anfossi G
Diabetes; 1995 Nov; 44(11):1318-22. PubMed ID: 7589830
[TBL] [Abstract][Full Text] [Related]
19. Specific inhibitory effects of the NO donor MAHMA/NONOate on human platelets.
Kobsar A; Simonis S; Klinker E; Koessler A; Kuhn S; Boeck M; Koessler J
Eur J Pharmacol; 2014 Jul; 735():169-76. PubMed ID: 24780647
[TBL] [Abstract][Full Text] [Related]
20. Synergism between collagen-adenosine diphosphate and collagen-epinephrine in platelets' aggregation: different dose response relationships.
Razi MS; Hameed W; Habib SS; Aslam M; Ashraf R
J Pak Med Assoc; 2009 Jun; 59(6):368-71. PubMed ID: 19534370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
